Cerus
CERS
#7755
Rank
โ‚น30.03 B
Marketcap
โ‚น156.27
Share price
-0.59%
Change (1 day)
20.90%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -โ‚น0.62 Billion

According to Cerus's latest financial reports the company's current earnings are โ‚น0.19 Billion. In 2024 the company made an earning of -โ‚น1.1 Billion, an increase over its 2023 earnings that were of -โ‚น2.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น0.62 Billion-44.27%
2024 -โ‚น1.1 Billion-58.95%
2023 -โ‚น2.68 Billion-20.74%
2022 -โ‚น3.38 Billion-25.7%
2021 -โ‚น4.55 Billion-11.99%
2020 -โ‚น5.17 Billion-14%
2019 -โ‚น6.01 Billion21.73%
2018 -โ‚น4.94 Billion-0.65%
2017 -โ‚น4.97 Billion-10.96%
2016 -โ‚น5.58 Billion4.24%
2015 -โ‚น5.35 Billion50.99%
2014 -โ‚น3.55 Billion-10.08%
2013 -โ‚น3.94 Billion184.13%
2012 -โ‚น1.39 Billion-7.91%
2011 -โ‚น1.51 Billion
2009 -โ‚น2.13 Billion-24.69%
2008 -โ‚น2.83 Billion-25.2%
2007 -โ‚น3.78 Billion330.54%
2006 -โ‚น0.88 Billion1.49%
2005 -โ‚น0.87 Billion-61.02%
2004 -โ‚น2.22 Billion
2002 -โ‚น5.49 Billion10.02%
2001 -โ‚น4.99 Billion34.25%
2000 -โ‚น3.72 Billion61.02%
1999 -โ‚น2.31 Billion-18.81%
1998 -โ‚น2.84 Billion93.08%
1997 -โ‚น1.48 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚น302.37 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚น1.35 B-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น22.44 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.88 Billion 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA